Clinical Trial

Post-Approval Study of the Neuspera Sacral Neuromodulation System

Study acronym: NSM-005
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System. Participants in this study received intervention/implanted in Phase I or Phase II of the Neuspera SANS\_UUI (NSM-004) Study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-25.
Status change: Not Yet Recruiting → Recruiting 2026-02-02
Trial Details
NCT Number NCT07144813
Lead Sponsor Neuspera Medical, Inc.
Conditions Urinary Urgency Incontinence
Enrollment 116 participants
Start Date 2025-09-03
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-04